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Avian infectious bronchitis virus (IBV) is one of the major viral respiratory diseases of chickens. Better 
understanding of the molecular mechanism of viral pathogenesis may contribute significantly to the 
development of prophylactic, therapeutic and diagnostic reagents as well as help in infection control. 
Avian IBV belongs to the Coronaviridaes and is similar to the other known coronaviruses. Previous 
studies have indicated that protein–protein interactions between nucleocapsid (N) and the membrane 
(M) proteins in coronavirus are related to coronavirus viral assembly. However, cases of IBV are seldom 
reported. In this study, yeast two-hybrid and co-immunoprecipitation techniques were applied to 
investigate possible interactions between IBV N and M proteins. We found that interaction of the N and 
M proteins took place in vivo and the residues 168 – 225 of the M protein and the residues 150 - 210 of 
the N protein were determined to be involved in their interaction. These results may provide some useful 
information on the molecular mechanism of IBV’s N and M proteins, which will facilitate therapeutic 
strategies aiming at the disruption of the association between membrane and nucleocapsid proteins 
and indicate a new drug target for IBV. 
 






Avian infectious bronchitis virus (IBV), a group of three 
member of the genus Coronavirus, is a highly infectious 
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respiratory tract as well as in epithelial cells of the gut, 
kidney and oviduct. It is of economic importance to the 
poultry industry due to the high morbidity and production 
losses associated with it. Clinical signs include: Tracheal 
rales, coughing, sneezing, poor weight gain and a decline 
in egg-shell quality and egg quantity. It may also cause 
the mixed infection of Mycoplasma gallisepticum and 
Escherichia coli as secondary infection and increase the 
mortality rate of poultry, causing a huge loss of poultry 
production (Yu et al., 2001; Liu and Kong, 2004; Alvarado 
et al., 2005).  
The disease is virtually pandemic and has been disco-
vered in North America, South America, Western Europe, 
Africa, China, Australia and New Zealand (Ignjatovic et 
al., 2006; Zhou et al., 2004; Bayry et al., 2005; Wang et 
al., 1997), where it has seriously endangered the world's 





difficult to prevent with therapeutics, thereby making it an 
extreme detriment to large-scale poultry production. 
Thus, the research of new technologies to prevent and 
treat the infectious bronchitis disease, and thereby reduce 
the enormous economic losses, becomes an urgent task 
to many researchers.  
The etiologic agent of infectious bronchitis (IB) is IBV, 
an enveloped, positive-sense and single-stranded RNA 
virus that belongs to the coronaviridae family. Like other 
coronavirus, the coronaviridae contains four structural 
proteins: Nucleocapsid surrounding the viral RNA, an 
integral membrane glycoprotein, a small envelope protein 
and a spike glycoprotein located on the surface of the 
viral envelope. Nucleocapsid (N) protein is the composi-
tion of the internal nucleocapsid protein of IBV virus. It 
occupies 40% of viral protein consisting of 409 amino 
acids, and can be phosphorylated. N protein plays an 
important role in viral replication and assembly (It et al., 
2001; Drees et al., 2001). The interaction of N protein 
and the sequence of pre-RNA contributes to the synthesis 
of viral mRNA and combines viral RNA to form a helical 
nucleocapsid binding. Several functions including viral 
packaging, viral core formation and signal transduction 
have been attributed to the coronavirus nucleocapsid (He 
et al., 2004; Hiscox et al., 2001).  
Membrane (M) protein accounts for about 40% of total 
protein, consisting of 224 - 225 amino acids. IBV M pro-
tein was predicted to span the membrane three times and 
display a short ectodomain and a large endodomain 
(Figure 3B) on the basis of other coronavirus M proteins 
(Runtao et al., 2004; Kuo and Masters, 2002; De et al., 1998). 
It is believed that the C-terminal endodomain interacts 
with N and S proteins (De et al., 1998), which plays an 
important role in the formation as well as assembly of the 
virus. Previous study showed that CoV- M and N proteins 
could interact with each other and were of great 
significance in the assembly of the virus (He et al., 2004; 
Hiscox et al ., 2001). The protein-protein interaction 
between Coronaviridae N and M proteins has been 
reported on mouse hepatitis virus and transmissible 
gastroenteritis (Narayanan and Makino, 2001; Kuo and 
Masters, 2002). The study of SARS also proved that M 
protein could interact with the N protein (Runtao et al., 
2004). However, the existence of such interaction in IBV has 
not been reported. In this research, the yeast two-hybrid 
and immunoprecipitation techniques were employed to 
study the interactions between M and N proteins in IBV, 
and elucidate the mechanism of molecular replication of IBV. 
 
 
MATERIALS AND METHODS 
 
Strains and general techniques  
 
The strain of Saccharomyces cerevisiae used in this study was 
AH109 from Clontech (USA). Yeast cells were cultured at 30°C 
either in a complete yeast peptone-dextrose (YPD) medium (1% 
yeast extract, 1% peptone, 2% glucose) or in a synthetic defined 
(SD) medium supplemented with required essential nutrients.  




Plates contained 2% agar. Transformation of yeast cells was 
performed by the lithium acetate medium. Escherichia coli JM109 
was used for general cloning. DNA manipulation was performed 
according to established protocol (Hiscox et al., 2001). Beta-




Plasmids and construction of recombinant vectors 
 
The full-length N and M gene of the IBV (SAIBk, AY282542) was 
polymerase chain reaction (PCR)-amplified from a genomic 
construct of clone and cloned into the pMD18-T vector (Takara, 
China). The full-length N and M geneS were subjected to DNA 
sequencing, and the inserts were verified against the corresponding 
region of the IBV (SAIBk) complete genome. The full-length N gene 
was excised from the pMD18-T–N construct using the restriction 
enzymes EcoRI and BamHI, and ligated into the pGBKT7 vector to 
generate an N-terminal in-frame fusion with the GAL4 activation 
domain (BD). The full-length M gene was digested from the pMD18-
T–M construct using the restriction enzymes EcoRI and PastI and 
ligated into the pGADT7 vector to generate an M-terminal in frame 
fusion with the GAL4 activation domain (AD). The full-length M 
gene was subcloned into the pCMV-HA vector (Clontech, USA), 
which carries HA tag. The full-length N gene was cloned into the 
pCMV-myc vector (Clontech,USA), which carries myc tag. The 
truncated mutants N1–149, N150–300, N301–409, N150–210 and 
N210–300 (constructs and putative functional domains are shown 
in Figure 3A) were subcloned into the yeast two-hybrid vector 
pGBKT7. The truncated mutants M1–29, M30–105, M106–225, 
M106–178 and M168–225 (constructs and putative functional 
domains are shown in Figure 3B) were subcloned into the yeast 
two-hybrid vector pGADT. All DNA manipulations were performed 
as described by Sambrook and Russell, (2001).  
 
 
Yeast transformation and culture 
 
Yeast two-hybrid experiments were conducted as described in the 
Clontech Manual for the MATCHMAKER GAL4 Two-Hybrid System 
and in the Clontech Yeast Protocols Handbook (Clontech, USA). 
The AH109 yeast strain was transformed with the appropriate 
plasmids, using the lithium acetate procedure and grown on SD 
plates in the absence of tryptophan (Trp) or leucine (Leu); (SD Trp− 
and SD Leu−). Protein interaction was tested on SD plates without 
Leu, Trp and adenine (Ade) (SD Leu− Trp− Ade−). After 48 – 96 h 
at 30°C, individual colonies were streaked out and tested for liquid 
and filter-lift β-galactosidase activity (Ober et al., 2002; Peiris et al., 
2003; Pewe et al., 2005). The filter β-galactosidase assay, a 
parameter directly reflecting the strength of protein–protein 
interactions, was performed by streaking doubly transformed yeast 
colonies onto filter paper and allowing them to grow for 2 days on 
selection medium. Yeast was permeabilized by freezing yeast 
impregnated filters in liquid nitrogen and thawing at room 
temperature. This filter was placed over a second filter that was pre-
soaked in Z buffer (pH 7.0).The liquid β-galactosidase activity was 
determined using the substrate o-nitrophenyl β-D-galacto-
pyranoside (OPNG). Relative enzymatic activity was determined in 
five independent transformants. Data for quantitative assays were 
collected for yeast cell number and were the mean ± S.E.M of 
triplicate assays. Appropriate positive/negative controls and buffer 
blanks were used. All the yeast media were prepared according to 
the standard Protocols Handbook (PT3024-1, Clontech, USA). 
 
 
Mammalian cell cultures 
 
The  vero  cell  was  obtained from Doctor Yunyi Yao (School of Life  




Science, Sichuan University). All cells were cultured at 37°C in 5% 
CO2 in Dulbecco's modified eagle's medium (DMEM) containing 1 
g/l glucose, 2 mM glutamine, 1.5 g/l sodium bicarbonate, 0.1 mM 
non-essential amino acids, 0.1 mg/ml streptomycin and 100 U 
penicillin, and 10% fetal bovine serum (FBS) (Invitrogen, USA).  
 
 
In vivo co-immunoprecipitation and western blotting 
 
To reaffirm the results observed from yeast two-hybrid assays, 
another independent assay, co-immunoprecipitation, was carried 
out. Vero cells were co-transfected with the plasmids expressing 
pCMV-myc-N and pCMA-HA-M using the Iipofectamine reagent 
(invitrogen). At 48 h post-transfection, cells were washed with 
phosphate buffered saline (PBS) and then lysed in lysis buffer. Cell 
lysate was mixed with anti-HA magnetic microbeads for 30 min on 
ice. 100 μl of 10% suspension of protein A–sepharose was then 
added to the samples. The mixture was allowed to shake for 1 h at 
4°C, the beads were washed four times in lysis buffer, and protein 
was eluted in 2× sodium doedecyl sulfate (SDS) dye by boiling the 
sample for 5 - 10 min. Samples were resolved by 10% SDS-
polyacrylamide gel electrophoresis (PAGE) and transferred to a 
nitrocellulose membrane. The membrane was blocked using 0.5% 
bovine serum albumi (BSA) in phosphate buffered saline with tween 
20 (PBST) for 2 h, and incubated overnight with anti-myc antibodies 
(1:1000; Clontech). The blot was then washed three times in PBST, 
incubated with anti-mouse IgG HRPO for 1 h and washed three 
times in PBST and the proteins were visualized with 5-bromo-4-
chloro-3-indolyl phosphate. The vero cells that transfected pCMV-





Identification of the interaction between N and M 
protein by yeast two-hybrid system 
 
To detect interaction between N and M proteins, a yeast 
two-hybrid technology based system was constructed. 
The recombinant plasmid PGBKT7-N contains the N 
coding sequence fused to the GAL4 DNA binding domain 
sequence, whereas, in PGADT7-M the M coding sequence 
was fused in-frame to the GAL4 activation domain 
sequence. Both constructs were co-transformed into 
AH109 and transformants were plated on medium lacking 
Trp, Leu and Ade (Figure 1A). Growth on Trp, Leu and 
Ade deficient medium demonstrates interaction of M and 
N proteins which results in reporter gene induction in the 
yeast strain. Moreover, the fact that the control yeast cells 
transformed with empty plasmids did not show cell growth 
(Figure 1A) suggested that this M/N interaction is specific 
in yeast. Accordingly, our yeast two-hybrid system was 
reliable and could be used for further research. To per-
form quantitative yeast two-hybrid tests between known 
proteins, beta-galactosidase assays were carried out. 
The interaction of N and M was obvious in the described 
data obtained in Figure 1B. 
 
 
Co-immunoprecipitation verifies the interaction of M 
and N proteins  
 
To examine further the interaction of the N and M 





cells were co-transfected with amino-terminal HA-tagged 
M and carboxy-terminal myc-tagged N and immuno-
precipitated with anti-HA magnetic microbeads, and 
washed extensively. The immunoprecipitated complexes 
were separated on SDS–PAGE and analyzed by western 
blot with anti-myc monoclonal antibodies. As shown in 
Figure 2, about 25 kD protein in accordance with M 
protein, was obtained from co-transfected cell, which 
showed that the myc-fused N protein immunoprecipitates 
with HA-M. Moreover, HA-M alone and myc-N alone could 
not be immunoprecipitated. These experiments confirm 
the results shown with the yeast two-hybrid system that 
the N protein can interact with M protein and indicate that 
interaction occurs in mammalian epithelial cells. 
 
 
IBV M/N interaction region mapping by yeast two-
hybrid assays 
 
In order to identify the interaction region, N protein of the 
IBV was divided into three domains (Figure 3A). The 
three sequences were cloned respectively, and connec-
ted with the yeast vector, pGBKT7. Three deletion 
mutants of N protein were constructed and put together 
with the pGADT7-M of yeast strain AH109 at a 
temperature of 30°C. Four to five days later, the detection 
of beta-galactosidase activity shows that the middle 
domain of 150 - 300 amino acids interacts with M (Figure 
3C). To further explore the binding fragment of M, N150-
220 (including SR-rich region) and N210-300 were studied 
by the constructed yeast two-hybrid system. The result 
(Figure 3C) indicates that the N150-220 fragment 
contains the domain which mediates the interaction of N 
with M protein. M protein of IBV was divided into three 
domains (Figure 3B), according to the secondary structure 
of M protein. We found that the large M endodomain (ME) 
could interact with N protein by yeast two-hybrid assays 
(Figure 3C). To map the involved regions of ME in the 
IBV N/M interaction, It was found that amino acids 168 - 
225, but not amino acids 106 - 178, could interact with N 
protein (Figure 3C). In summary, the residues 168 - 225 
of IBV M and the residues 150 210 of IBV N protein were 





In this study, by yeast two-hybrid and immunopreci-
pitation techniques, we fully characterized IBV M/N 
interaction. It was found that the residues 168 – 225 of M 
protein and the residues 150 - 210 of N protein contri-
buted to this interaction. Interaction between M and N in 
coronaviruses has been reported in literatures (; Kuo and 
Masters, 2002; De et al., 1998; Opstelten et al., 1995 
Kelley et al., 2005). We found that the residues 168 - 225 
of IBV M protein might contribute greatly to IBV M/N 
interaction, which seems to be compatible with the 
reported result that the M protein binds to
































Figure 1. Yeast two-hybrid analysis of the IBV N and M protein interaction. A: Yeast two-hybrid assay of pGBKT7-
N+pGADT7; pGBKT7+pGADT7-M; pGBKT7-N+pGADT7-M; positive control, pGBKT7-53+ pGADT7-T; negative control, 
pGBKT7-Lam+ pGADT7-T; B: Yeast two-hybrid quantification of β -galactosidase activity. The plasmid pairs above 
were cotransfected into the AH109 yeast strain, and assessed for β-galactosidase activity. Results shown are the 






Figure 2. M protein immunoprecipitated with the IBV- N protein. Indicated 
plasmids were simultaneously transfected into vero cells. Twenty-four hours after 
transfection, coimmunoprecipitation was performed using anti-HA magnetic 
microbeads. The proteins immunoprecipitated (IP) were assayed with an anti-
myc monoclonal antibody. M, Marker; 1, HA-M+myc-N; 2, HA-M; 3, myc-N. 






Figure 3. Mapping the domains involved in IBV M/N interaction by the yeast two-hybrid assay. A: Schematic representation of the IBV 
N protein and the truncated mutants used in the yeast two-hybrid system, the SR-rich motif is highlighted; B: schematic representation 
of the IBV M protein and the truncated mutants used in the yeast two-hybrid system. M protein is composed of three domains: a short 
N-terminal ectodomain, a triple-span transmembrane domain and a C-terminal endodomain; the ectodomine, transmembrane 
fragment and endomain; C: mapping the domains involved in IBV M/N interaction. The empty vectors pGBKT7 and pGADT7 co-
transformed were used as the negative control and the pGBKT7-53 and pGADT7-T co-transformed were used as the positive control. 
Every experiment was repeated for at least three times and the data were obtained by average. The error bars represent standard 






nucleocapsid with its carboxyl terminus in mouse 
hepatitis virus (Kuo and Masters, 2002; Narayanan et al., 
2000; Kelley et al., 2005), transmissible gastroenteritis 
corona-virus (TGEV) and severe acute respiratory 
syndrome (SARS) (Hatakeyama et al., 2008; Hsieh et al., 
2008). These results indicated that the C-terminal polar 
tail within the endodomain of M protein could interact with 
N proteins, indicating that the large ME probably plays a 
major role in IBV assembly. 
Mapping studies localized the critical N sequences for 
this interaction to amino acids 150 - 210, which includes 
the SR-rich motif (containing rich serine and arginine). 
SR-related proteins are often involved in protein-RNA 
and protein–protein interactions (Blencowe et al., 1999) 
and the SR-rich motif is conserved in the N protein of 
coronavirus. It has been reported recently that SR-rich 
motif is indispensable for SARS N oligomerization and for 
N protein interaction with SARS-CoV membrane protein 
(He et al., 2004). The SR-rich motif is also responsible for 
the interaction with hnRNPA1 in MHV (Wang and Zhang, 
1999) and SARS (Haibin et al., 2005). In addition, this 
motif is also involved in interaction with SARS Hubc9 
(Fan et al., 2006). All these facts indicate that the SR-rich 
motif of the N protein might play a crucial role in IBV 
infection. However, this result seems not to be compatible 
with the reported result that the N protein binds to M 
protein with its carboxyl terminus in mouse hepatitis virus 
(Kuo and Masters, 2002) and SARS-CoV (Hatakeyama 
et al., 2008; Hurst et al., 2009), which may be that IBV 
nucleocapsid protein possess low homology with others 
in the coronaviral family. 
Our present study revealed that the M-N protein-protein 
interaction exists in IBV as it does in other members of 
the Coronaviridae family, thereby reinforcing a notion that 
the importance of M–N interaction in viral interaction 
appears to be an essential process for coronaviral assembly 
(He et al., 2004; Hiscox et al., 2001). 
In summary, our data has shown for the first time that 
the IBV N and M proteins can interact with each other in 
vivo and this interaction appears to be significant for one 
of the critical steps of viral assembly and maturation process. 
The SR-rich motif of the N protein and endo-domain of 
the M protein play crucial role in CoV virus assembly. This 
current research contributes useful data that will shed 
light on the molecular mechanism of IBV M/N interaction 
and provide valuable clues for mutagenic studies in 
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